| Janssen-Cilag AG - Stelara 130 mg, Konzentrat zur Herstellung einer Infusionslösung | | 66135 | | 01 | | Stelara 130 mg | | Konzentrat zur Herstellung einer Infusionslösung | | L04AC05 | | Ustekinumab | | 02.06.2017 | | |
| | Composition | | ustekinumabum 130 mg, histidinum, histidini hydrochloridum monohydricum, saccharum, polysorbatum 80, dinatrii edetas, methioninum, aqua ad iniectabile q.s. ad solutionem pro 26 ml, natrium 2.5 µg/ml. | | Packungsbestandteile | | Concentrate for infusion | | | | | | | | Active Agent | Dose |
|---|
| Ustekinumabum | 130mg / 26ml |
| | BAG: Active Agent | Dose |
|---|
| Ustekinumabum | 130 mg |
| | | | Inactive agents |
|---|
| Dinatrii Edetas | | Histidin Hydrochloride Monohydrate | | Histidine | | Methionine | | Polysorbatum 80 | | Saccharum |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 3074.64 | 3360.25 | B | SL | No |
|
|
